chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Headache; muscle aches; low grade fever; fatigue; This is a spontaneous report from a contactable other HCP (patient). A 30-year-old female (non-pregnant) patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EL9264, Expiration Date: not reported) via intramuscularly in left arm on 03Feb2021 11:45 (at the age of 30-years-old) as 2nd dose, single dose for COVID-19 immunization. The patient historic vaccine included first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number EL1283, Expiration Date: unknown), via Intramuscularly in left arm on 12Jan2021 05:00 PM at 1st dose, single dose for COVID-19 immunization. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history was not reported. Concomitant medications included other medications the patient received within 2 weeks of vaccination of Effexor 75 mg, Magnesium 50 mg, Iron 50 mg. On 03Feb2021 at 15:00, the patient experienced headache, muscle aches, low grade fever, fatigue. Prior and post to vaccination, the patient was not diagnosed with COVID-19. Treatment was not received for the adverse events. The outcome of the events was reported as recovering.  Follow-up attempts are completed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment
Clinical narrative: I had a lapse of memory and was told that I repeated words three times, consistently for approximately ten minutes; This is a spontaneous report from a contactable other hcp. A 68-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 03Feb2021 at 12:00 (at the age of 68-year-old) as 2nd dose, single for COVID-19 immunization. Medical history included coronary artery disease (CAD) and diabetes. Allergies to medications, food, or other products was reported as NKDA. The patient had received other vaccines within 4 weeks prior to the COVID vaccine. The patient had previously received BNT162B2 for covid-19 immunization on 13Jan2021. The patient experienced a lapse of memory and was told that she repeated words three times, consistently for approximately ten minutes on 04Feb2021 at 12:00 pm. No treatment was provided for the events. The event was not serious, and it did not cause life threatening or fatal outcome. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the event was unknown.   Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (Reporter's daughter) reported. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as 1st dose, single dose for covid-19 immunisation. Patient received the 1st dose, she developed rash. The outcome of the event was unknown.  Information about batch/lot number has been requested.  Follow-up attempts are completed. No further information is expected.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Night sweats
Clinical narrative: Night sweats; chills; This is a spontaneous report received from a contactable consumer (reporting for herself). A 89-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in left arm on 23Jan2021 16:00 as single for covid-19 immunisation. The patient's medical history included diabetes, congestive heart failure and cancer from an unknown date and unknown if ongoing. The patient previously took codeine and experienced drug hypersensitivity. The patient had no covid prior vaccination. Since the vaccination, the patient not been tested for covid-19. The patient was not pregnant at time of vaccination. The patient's concomitant medications were not reported. On 02Feb2021, the patient experienced night sweats and chills. Treatment was not received for events. The events were assessed as non-serious by reporter. Outcome of the events was not recovered.  Information on the lot/batch number has been requested.  Follow-up (12MAY2021): Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Pain in extremity
Clinical narrative: This is a spontaneous report from contactable consumer (patient) by a Pfizer sponsored program Pfizer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No allergies to medications, food, or other products. The patient was about to take the second dose on 11 Feb; however, she needs to take PRP as well (To fertilize stem cells); she was asking if she needs to reschedule her PRP; the reporter considered the events as non-serious. As of 26Feb2021, patient reported that both shots of Pfizer vaccine were taken on an unspecified date and she had a sore arm for a few days on an unspecified date (no further information provided.) Outcome of the events was unknown. Information on Lot/Batch number has been requested. Follow-up (26Feb2021): New information reported from the same contactable consumer (patient) includes clinical course with new event (sore arm). This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: spotted bruises on my dorsal left arm; This is a spontaneous report from a contactable consumer (patient). A 28-year-old non pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection, Lot Number: EL283), via an unspecified route of administration, administered in left deltoid on 29Jan2021 (at the age of 28-year-old) at a single dose for covid-19 immunisation. The patient had no medical history and was not allergic to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication (received within 2 weeks) included Ibuprofen (ADVIL). Patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination the patient was not tested for COVID-19. On 04Feb2021, the patient noticed spotted bruises on her dorsal left arm. Patient did not receive any treatment for the event. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion
Clinical narrative: stuffy nose; This is a spontaneous report from a Pfizer-sponsored program and a contactable consumer(patient). A female patient of unspecified age received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE,Formulation: Solution for injection, Lot number and expiry date were unknown) via an unspecified route of administration on an unknown date in Jan21 as a single dose for COVID-19 immunzation. The patient medical history and concomitant mediations was not reported. On an unknown date patient had stuffy nose.Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: painful; This is a spontaneous report was received from a Pfizer sponsored program. A contactable female consumer (Patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/lot number: not reported), via an unspecified route of administration on an unspecified date as a 2nd dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient got the second dose and felt so painful, they took tylenol and read that it would interfere with the vaccine.The outcome of the event was unknown.  Information on the Batch/Lot number has been requested. Follow-up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Headache, Oropharyngeal pain
Clinical narrative: difficulty breathing; severe sore throat; headache; At Injection felt woozie; This is a spontaneous report from a contactable consumer (patient reported herself). A 42-years-old female patient (non-pregnant) received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN5318), via an unspecified route of administration in left arm on 27Jan2021 at 1: 10 PM (at the age of 42 years 10 months, non-pregnant) as 0.3ML single dose for covid-19 immunisation. Medical history included polycystic ovaries, diabetes mellitus (ongoing), gastrooesophageal reflux disease, hypertension (HBP) and allergy to Red plums. Concomitant medications included Dienogest, estradiol valerate (NATAZIA), Metformin , Glimepiride,Insulin glargine (TOUJEO) for diabetes mellitus, Spironolactone , Lisinopril , Atorvastatin ,Omeprazole ,Amlodipine and vitamin D NOS for all the indication and medication dates were not reported except the indication for Insulin glargine (TOUJEO). The patient previously experienced allergy to Cipro [ciprofloxacin], Keflex [cefalexin] and Betadine [povidone-iodine]. There were no other illnesses reported at the time of vaccination and up to one month prior to the vaccination. On 27Jan2021, at 2:20 PM after the vaccination, the patient experienced At Injection felt woozie, thought just needed to eat 1 hr after injection, difficulty breathing, severe sore throat, headache. The patient visited Emergency room/department or urgent care due to the events. The patient was not resolved from the adverse events.    Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Heart rate, Heart rate increased, Pain in extremity
Clinical narrative: Pain in arm; Headache; Increased heart rate; Difficulty breathing; This is a spontaneous report from a contactable other HCP (patient). A 51-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3246), via an administered in right arm on 28Jan2021 10:45 as a 1st dose, single for COVID-19 immunisation. The patient's medical history included Known Allergies: PCN, Sulfa, chemical sensitivities. The patient's concomitant medications included EPO, Fish oil w/D (FISH OIL + VITAMIN D3), MAGNESIUM CITRATE, Polyphennutri, Prob, ZYRTEC [CETIRIZINE HYDROCHLORIDE]. The patient had no covid-19 infection prior to vaccination. Facility type vaccination was reported as other. The patient was not on other vaccine in four weeks prior to COVID-19 vaccination. It was unknown if the patient was covid tested post vaccination. On 28Jan2021, the patient experienced pain in arm, headache, increased heart rate, slight difficulty breathing. The patient had not received treatment medications as a result of events. Lab test included on 28Jan2021, heart rate: increased. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information was expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Gait disturbance, Head discomfort, Vertigo
Clinical narrative: Kind of vertigo; All of sudden she felt unbalanced; Like her head was heavy; she was holding onto things when she walked; This is a spontaneous report from a contactable consumer (patient). An 80-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 28Jan2021 15:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included visually handicapped and could not read her vaccine card; vertigo before, a year ago. There were no concomitant medications. The patient had her first COVID 19 vaccination, on 28Jan2021, about 3PM and she will get the booster on 22Feb2021, but it seemed like she had kind of vertigo on 29Jan2021, this just happened in the last hour, all of sudden she felt unbalanced, like her head was heavy, and she was holding onto things when she walked, She did call her primary doctor, he didn't think it had to do with the vaccine, so she thought to call and ask, she was fine, and then all of a sudden she started to get this kind of vertigo, he asked if her head was spinning, but it's not, it felt heavy and she has had vertigo before, a year ago, but she doesn't know. Her doctor told her to rest, so she was laying down, and when she lifted her head she could feel, it was not spinning, she knew she was not feeling balanced. When asked to clarify her question, states she wasn't sure this happening had anything to do with the vaccination, she called her primary care doctor and he thought it wasn't, had nothing to do with it, so she thought since she called, she would wait and talk to Pfizer in case, that other people have experienced the same thing. States she was hoping this agent could tell her it would go away in a little while, but her primary care doctor said it has nothing to do with it, but it may have to do with it, it was somewhat of a coincidence that was happened, and she was fine for 24 hours, all of a sudden she started to feel this whatever. States she did not need anything else at this time. Outcome of the event vertigo was not recovered and all other events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was real sore; couldn't almost lift it; This is a spontaneous report from a contactable consumer (patient). A 82-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9261, Expiration date: 31May2021), via an intramuscular route on 22Jan2021 at 13:00 (at the age of 82-years-old) as 1st dose, single in the deltoid right for covid-19 immunisation. The patient medical history included trigeminal neuralgia diagnosed with this condition at least a good 10 years ago. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included TOPAMAX tablet with dose 150 mg, daily, (one 50 mg, tablet, by mouth, once in the morning; two tablets at night /Total of 150 mg daily) for trigeminal neuralgia. Caller received the COVID vaccine on 22Jan2021 and five days later on 27Jan2021 at 20:00, the patient arm was real sore and she couldn't almost lift her arm which she thought was an unusual reaction. She doesn't believed she did anything to her arm. She doesn't know if she pulled a muscle or anything. By the next morning, 28Jan2021, the soreness was gone and was fine. She hasn't had any problem since. The outcome of the events was recovered on 28Jan2021.  Follow-up attempts are completed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Malaise
Clinical narrative: Awful taste in mouth; feels pretty lousy; This is a spontaneous report from a contactable consumer (patient). A 44-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9261), dose 1 via an unspecified route of administration in arm left on 28Jan2021 at 12:30 as a 1st dose, single for COVID-19 immunisation. The patient's medical history included depression. The concomitant medications included bupropion hydrochloride (WELLBUTRIN) taken for depression, from 28Jan2021 and ongoing. The patient did not had a history of immunization which would considered as suspect with the Pfizer vaccine and did not administer any vaccine on same date of the Pfizer suspect or within 4 weeks. The patient did not receive vaccine since she was a kid, she did not know any adverse event following prior vaccination. The patient reported that with Wellbutrin, it was a double whammy, she felt like crap. On 28Jan2021 at about 12:45 to 13:00, the patient experienced awful taste in mouth. The patient reported that she could taste the vaccine and it was over 24 hours and the taste did not go away. The patient ate sauerkraut and sour patch kids, the taste was so awful. She did not receive the flu shot, she struggles with medications in general. That was not the first time she tasted the medications, which was the reason why she could not handle the taste. On an unspecified date in 2021, the patient felt pretty lousy. The patient wanted the taste to go away, it was horrible and she would tough it out. There was no family medical history relevant to adverse event and the patient did not undergo relevant lab tests. The outcome of the event awful taste in mouth was not recovered and was unknown for feels pretty lousy.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Malaise
Clinical narrative: Chest heaviness; Difficulty breathing; Not feeling well; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/lot number, NDC number and Expiry Date were not Provided), via an unspecified route of administration on an unspecified date in Jan2021 as UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that, caller received her COVID vaccine about an hour and a half ago. She experienced some heaviness in her chest and difficulty breathing on 29Jan2021. The caller had declined to complete a report at that time, stating she was really not feeling well (on an unspecified date in 2021). The outcome of the events was unknown.  Lot/Batch number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site pain
Clinical narrative: pain in his arm; Flu like symptoms; This is a spontaneous report from non-contactable nurse via Pfizer Sales Representative. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Batch/Lot number was not reported, Expiration Date was not reported), via an unspecified route of administration, administered in arm  on an unspecified date as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that,  Caller is a representative for the company, and was in conversation with nurse, and informed her, though  caller does not have details, but the reporter's husband received the Pfizer COVID 19 vaccine and experienced pain in his arm and flu like symptoms the next day. Patient details: initials, age of onset, date of birth,  height, weight and ethnicity are unknown. The reporter didn't explicitly say her husband was in the country, but didn't say he was out of the country. Dates and outcome unknown, the reporter just said it was the following day, caller believes the reporter said it was the first dose. The outcome of the events was unknown.  No follow up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: very fatigued after 2nd dose, for about a week; This is a spontaneous report from a non-contactable consumer or other non HCP.   A adult male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot number: not reported) on an unspecified date for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was unknown If patient received other vaccine in four weeks. The patient experienced very fatigued after 2nd dose, for about a week on an unspecified date. It was unknown if the patient was diagnosed Prior and post to vaccination, with COVID-19. Patient did not received any treatment for the event. The outcome of the event was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Nasopharyngitis, Pyrexia, Tremor
Clinical narrative: Chills; she threw up; shaking; feel very bad; little cold like she may have a fever; little cold like she may have a fever; This is a spontaneous report from a contactable consumer reported for his wife. A 70-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: unknown), via an intramuscular route of administration in left arm on 27Jan2021 at 15:00 (at the age of 70-years-old), as single dose for covid-19 immunisation. No additional Vaccines administered on the Same date of the Pfizer Suspect. No Prior Vaccinations within 4 weeks of the vaccination was received by the patient. No adverse events following prior vaccinations reported. The patient had no medical history, and no concomitant medications were received. The patient had no history of all previous immunization with the Pfizer vaccine considered as suspect. On 29Jan2021, 2 days after receiving the vaccine, the patient experienced chills, threw up, shaking, started to feel very bad and hadlittle cold and fever. It was reported that she felt fine the day of getting the vaccine and yesterday and about 2 hours ago today, she had bad chills and threw up. She felt better once she threw up. She still feels a little cold like she may have a fever, but the shaking is over. The patient did not visit emergency room and physician Office. No relevant rests were conducted. The event shaking was resolved on an unspecified date in 2021. The outcome of the event threw up was resolving. The outcome of the other events was not reported. The reporter wants to know if these side effects are still associated with the vaccine. No investigation assessment was provided.   Information about Batch/Lot number has been requested   Follow-up attempts are completed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Chills; she threw up; shaking; feel very bad; little cold like she may have a fever; little cold like she may have a fever; This is a spontaneous report from a contactable consumer reported for his wife. A 70-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: unknown), via an intramuscular route of administration in left arm on 27Jan2021 at 15:00 (at the age of 70-years-old), as single dose for covid-19 immunisation. No additional Vaccines administered on the Same date of the Pfizer Suspect. No Prior Vaccinations within 4 weeks of the vaccination was received by the patient. No adverse events following prior vaccinations reported. The patient had no medical history, and no concomitant medications were received. The patient had no history of all previous immunization with the Pfizer vaccine considered as suspect. On 29Jan2021, 2 days after receiving the vaccine, the patient experienced chills, threw up, shaking, started to feel very bad and hadlittle cold and fever. It was reported that she felt fine the day of getting the vaccine and yesterday and about 2 hours ago today, she had bad chills and threw up. She felt better once she threw up. She still feels a little cold like she may have a fever, but the shaking is over. The patient did not visit emergency room and physician Office. No relevant rests were conducted. The event shaking was resolved on an unspecified date in 2021. The outcome of the event threw up was resolving. The outcome of the other events was not reported. The reporter wants to know if these side effects are still associated with the vaccine. No investigation assessment was provided.   Information about Batch/Lot number has been requested   Follow-up attempts are completed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: After the first dose she had mild pain all over body; This is a spontaneous report from a contactable Consumer reported for herself.   A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3249, Expiry Date: Not Provided), via unspecified route of administration in left arm as 1st dose, single dose on 06Jan2021 for COVID-19 immunisation. Relevant medical history was none. Concomitant medications included She takes birth control pills regularly. She had Excedrin for migraine pain, she took it after the vaccine. The patient had reported that with the first dose patient had mild pain all over the body. Patient also wanted to know what she should do next and if this is a normal Side effect as patient was frustrated asking how long she would have to wait for the other department, She waited 1 hour just to give all this information and now she is going to be transferred again. Outcome of event was unknown  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymph node pain, Lymphadenopathy, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Swollen and painful lymph nodes; Swollen and painful lymph nodes; Headache; Pain in the site of injection; This is a spontaneous report from a Non-Contactable Other health care professional reported that a 35-year-old female (Non-pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EL9262), via an Intramuscular in left arm on 26Jan2021 at 12:30 and first dose (Lot Number: EL1283) via an Intramuscular in left arm on 05Jan2021 12:30 both at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. No known allergies reported. No prior vaccinations within 4 weeks. The patient was not diagnosed with COVID-19 prior to vaccination. The patient tested with COVID-19 post vaccination. On 28Jan2021 18:00, the patient experienced swollen and painful lymph nodes, headache, and pain in the site of injection. On 11Jan2021, the patient underwent lab tests and procedures which included covid test type post vaccination, nasal swab result was negative. Patient did not received treatment for adverse event. The outcome of events was not unknown.   No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Dyspnoea, Palpitations, Pruritus
Clinical narrative: My heart was racing and heart beat was quite rapid; I start having some labor breathing not real difficulty in breathing but just like slight asthma attack; My lungs kind of tightened up; Cough kind of lingered for while I was kind of clearing my lungs or something; It was kind of itching across my chest and under my neck; red kind of rash across my chest; It was kind of itching across my chest and under my neck; red kind of rash across my chest; This is a spontaneous report from a contactable consumer. A 67-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL8982) via an unspecified route of administration, on 25Jan2021 at 3:45 as a single dose (at the age of 67-year-old) for COVID-19 immunisation. The patient's medical history included Blood pressure high and Atrailfibrillation. It was reported that she was not been taking metoprolol and also she was not took at the time of vaccination. On 25Jan2021, 5 minutes after vaccination, the patient reported that her heart was racing and heart beat was quite rapid (PT: palpitations), she started experiencing some labor breathing not real difficulty in breathing, but just like slight asthma attack (PT: dyspnoea), her lungs was a kind of tightened up (PT:chest discomfort), cough kind of lingered for while and she was a kind of clearing her lungs or something (PT: cough), she also experienced a kind of itching across her chest and under her neck (PT: pruritis) and red kind of rash across her chest (PT: rash). The patient did not received any treatment. Clinical course reported includes; rapid heart about 5 minutes, after that started having some labor breathing not real difficulty in breathing but just like slight asthma attack. The patient's lungs kind of tightened up, was having the labor little bit of breathing but not seriously that concerned that much. It says patient was out of statics 4'oclock which was 15 minutes after the shots. Rapid heartbeats slowed down and got back to normal. labor breathing lasts till about 3 am in the morning and patient woke up and labor breathing was kind of gone away and was breathing back to a normal pace but also started after that leathery cough. So that cough lasted till 3PM, 6PM next day. So about 24 hours, this cough kind of lingered for while patient was kind of clearing lungs, was kind of itching across the chest and under the neck. It was quite itchy so was kind of scratching out of it. Patient was just in shower tonight, noticed had a red kind of rash across the chest. The patient was reported that she was little concerned about the second dose but she was okay to take her second dose. On 25Jan2021, the outcome of the event palpitations was recovered. On 26Jan2021, the outcome of the events dyspnoea, chest discomfort, cough was recovered. The outcome of the event pruritis was unknown. The outcome of the event rash was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: My heart was racing and heart beat was quite rapid; I start having some labor breathing not real difficulty in breathing but just like slight asthma attack; My lungs kind of tightened up; Cough kind of lingered for while I was kind of clearing my lungs or something; It was kind of itching across my chest and under my neck; red kind of rash across my chest; It was kind of itching across my chest and under my neck; red kind of rash across my chest; This is a spontaneous report from a contactable consumer. A 67-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL8982) via an unspecified route of administration, on 25Jan2021 at 3:45 as a single dose (at the age of 67-year-old) for COVID-19 immunisation. The patient's medical history included Blood pressure high and Atrailfibrillation. It was reported that she was not been taking metoprolol and also she was not took at the time of vaccination. On 25Jan2021, 5 minutes after vaccination, the patient reported that her heart was racing and heart beat was quite rapid (PT: palpitations), she started experiencing some labor breathing not real difficulty in breathing, but just like slight asthma attack (PT: dyspnoea), her lungs was a kind of tightened up (PT:chest discomfort), cough kind of lingered for while and she was a kind of clearing her lungs or something (PT: cough), she also experienced a kind of itching across her chest and under her neck (PT: pruritis) and red kind of rash across her chest (PT: rash). The patient did not received any treatment. Clinical course reported includes; rapid heart about 5 minutes, after that started having some labor breathing not real difficulty in breathing but just like slight asthma attack. The patient's lungs kind of tightened up, was having the labor little bit of breathing but not seriously that concerned that much. It says patient was out of statics 4'oclock which was 15 minutes after the shots. Rapid heartbeats slowed down and got back to normal. labor breathing lasts till about 3 am in the morning and patient woke up and labor breathing was kind of gone away and was breathing back to a normal pace but also started after that leathery cough. So that cough lasted till 3PM, 6PM next day. So about 24 hours, this cough kind of lingered for while patient was kind of clearing lungs, was kind of itching across the chest and under the neck. It was quite itchy so was kind of scratching out of it. Patient was just in shower tonight, noticed had a red kind of rash across the chest. The patient was reported that she was little concerned about the second dose but she was okay to take her second dose. On 25Jan2021, the outcome of the event palpitations was recovered. On 26Jan2021, the outcome of the events dyspnoea, chest discomfort, cough was recovered. The outcome of the event pruritis was unknown. The outcome of the event rash was not recovered.   Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain, Vaccination site pain
Clinical narrative: Feeling tiredness; Injection site pain; Muscle pain all over the body; Soreness all over; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 79-years-old patient of an unspecified gender received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified), via an unspecified route of administration on an unspecified date as 1st DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, 14 hours post vaccination the patient started feeling tiredness, injection site pain, muscle pain all over the body. The patient then went to bed woke up in the morning with initial feeling of soreness all over but it quickly disappeared, and the patient felt normal and also ecstatic. The outcome of the event was reported recovered on an unknown date.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Influenza like illness, Nausea
Clinical narrative: Fly like symptoms; fever; body aches; chills; shaking; fatigue; joint pain; nausea; This is a spontaneous report from a contactable other-HCP (patient herself). A 39-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration in right arm on 18Jan2021 09:00 as 1st dose single for COVID-19 immunization. Patient was 39-years-old and was not pregnant at the time of vaccination. Patient did not receive any other vaccines in four weeks. Patient did not had COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Patient medical history included asthma, known allergies, hypothyroidism, IBS, chronic migraine. The concomitant medications included antibiotic, prednisone, levothyroxine sodium (LEVOTHYROXIN). On 18Jan2021 at 17:00, patient experienced flu-like symptoms till 19Jan2021 then ran into fever, body aches, chills, shaking. On 24Jan2021, no fever just body aches and fatigue. Patient experienced fever and joint pain in between 25Jan2021 to 27Jan2021. On 28Jan2021 experienced body aches, chills, nausea. Patient did not receive any treatment for the adverse events. The lab test and procedure included Rapid Covid (Nasal Swab) test on 25Jan2021, with test result as negative. The outcome of the events was not recovered.  Information on lot/batch number has been requested  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test, Tremor
Clinical narrative: Fly like symptoms; fever; body aches; chills; shaking; fatigue; joint pain; nausea; This is a spontaneous report from a contactable other-HCP (patient herself). A 39-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration in right arm on 18Jan2021 09:00 as 1st dose single for COVID-19 immunization. Patient was 39-years-old and was not pregnant at the time of vaccination. Patient did not receive any other vaccines in four weeks. Patient did not had COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Patient medical history included asthma, known allergies, hypothyroidism, IBS, chronic migraine. The concomitant medications included antibiotic, prednisone, levothyroxine sodium (LEVOTHYROXIN). On 18Jan2021 at 17:00, patient experienced flu-like symptoms till 19Jan2021 then ran into fever, body aches, chills, shaking. On 24Jan2021, no fever just body aches and fatigue. Patient experienced fever and joint pain in between 25Jan2021 to 27Jan2021. On 28Jan2021 experienced body aches, chills, nausea. Patient did not receive any treatment for the adverse events. The lab test and procedure included Rapid Covid (Nasal Swab) test on 25Jan2021, with test result as negative. The outcome of the events was not recovered.  Information on lot/batch number has been requested  Follow-up attempts are completed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Malaise, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Pain at injection site; fever; severe malaise; muscle and joint aches; muscle and joint aches; This is a spontaneous report from a non-contactable consumer or other Non-health care professional.   A 54-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), via an unspecified route in Arm Left on 28Jan2021 14:00 as 2ND DOSE, SINGLE for covid-19 immunization. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), via unspecified route in arm left on 07Jan2021 14:00 at a single dose for COVID-19 immunization. Medical history included hypertension from an unknown date and unknown if ongoing, anxiety from an unknown date and unknown if ongoing, sleep apnoea syndrome from an unknown date and unknown if ongoing. Concomitant medications included escitalopram oxalate (LEXAPRO), omeprazole (OMEPRAZOLE), zolpidem tartrate (AMBIEN), metoprolol (METOPROLOL XL SANDOZ). The patient previously took amoxil and experienced drug hypersensitivity (Known allergies). It was reported that patient had not received other vaccine in four weeks. Patient had not undergone any covid test prior to vaccination and had not experienced any covid events prior to vaccination. The patient experienced pain at injection site, fever (12 hours later), severe malaise, muscle and joint aches on 29Jan2021 02:00. Patient had not received any treatment for events. Outcome of the events was recovering.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Culture urine, Investigation, Urinary tract infection
Clinical narrative: I felt like I had a UTI; This is a spontaneous report from a contactable Retired Nurse (patient).  A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation solution for injection; Lot number: EL1283), via an unspecified route of administration on 28Jan2021, as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the Nurse (patient) felt like to have an UTI (urinary tract infection). The Nurse got the Pfizer Covid vaccine yesterday and had the issue hence went to the Gynaecologist on Tuesday because nurse felt like to have an UTI. However, the Gynaecologist said it did not look like it was an UTI and investigated for urine which looked negative. The nurse's urine was sent out for a culture which came positive. Therefore, the gynaecologist wanted to treat the nurse with Cipro for 3 days, but the nurse had a question if Cipro could be taken after just taking the vaccine. Nurse was informed about role Pfizer Drug Safety department and asked for the permission to probe further question to which the Nurse denied hence further probing could not be done. On an unspecified date, the patient underwent laboratory investigations included urine investigation which looked negative and urine culture showed positive. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash pruritic, SARS-CoV-2 test
Clinical narrative: I noticed severe itching on my left upper thigh with bumps and after this shot; itching has spread to face and arms; This is a spontaneous report from a contactable other health professional (patient) reported for herself that a 40-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL0140), via intramuscular route of administration, administered in right arm (at the age of 40 years) on 08Jan2021 as 1ST DOSE, SINGLE for COVID-19 immunization. Medical history included sinus tachycardia, panic disorder, depression, chronic fatigue syndrome, PCOS and allergic to Penicillin. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included Metformin 500mg, Metoprolol 50 mg, Paroxetine 50 mg and Vitamin D, which were received by the patient within 2 weeks of vaccination and all were taken for an unspecified indication, start and stop date were not reported. The most recent COVID-19 vaccine was administered at nursing Home/Senior Living Facility. On an unknown date, 2 weeks or so after first shot, the patient was noticed severe itching on my left upper thigh with bumps and after this shot, itching has spread to face and arms. Clinical course was reported as: On 20Jan2021, Joint and muscle pain and extreme fatigue that started on days 3+ (slept over 20 hours day 4, plus 12 day 5 and still exhausted). Congested with runny nose and itchy eyes and just generally feeling ill. 2 weeks or so after first shot, she noticed severe itching on her left upper thigh with bumps and after this shot, itching spread to face and arms. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient been tested for COVID-19. The patient underwent lab tests and procedures which included sars-cov-2 test/ oropharyngeal swab test: negative on 01Feb2021. Patient did not receive treatment for the adverse event. The case was considered as non-serious as per reporter. Outcome of the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Vacinated on 22Jan2021 at 3pmgot dizzy, nausea and vomitted on 23Jan2021 at 4.pm Got Dizzy, nausea and vomited again on 29Jan2021 at 4 pm; Vacinated on 22Jan2021 at 3pmgot dizzy, nausea and vomitted on 23Jan2021 at 4.pm Got Dizzy, nausea and vomited again on 29Jan2021 at 4 pm; Vacinated on 22Jan2021 at 3pmgot dizzy, nausea and vomitted on 23Jan2021 at 4.pm Got Dizzy, nausea and vomited again on 29Jan2021 at 4 pm; This is a spontaneous report from a non-contactable consumer or other non hcp (patient).   A male patient (at the age 76, unit was unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9261), via an unspecified route of administration, on 22Jan2021at 15:00 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was unknown whether the patient had covid prior to vaccination. On 22Jan2021 at 16:00, the patient got dizzy, nausea and vomited and on 29Jan2021 at 16:00, the patient again got dizzy, nausea and vomited. No treatment was given for the adverse events. Patient was not tested for covid post vaccination. At the time of this report event outcome was unknown.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy; This is a spontaneous report from a non-contactable consumer (patient). A 52-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: unknown), via intramuscular route on 14Jan2021 13:20 as 1st dose, single dose in Arm Right for COVID-19 immunization. The patient medical history included stuffy nose (from 11Jan2021 to an unknown date), she mentions her nose may have been a little stuffy at the time she was vaccinated. The patient did not receive prior vaccinations within 4 weeks. The concomitant medications were not reported. On an unspecified date in Jan2021, the patient experienced dizzy. Clinical course included: the patient received her first COVID-19 vaccine, she did not have any side effects until day 7. She got very dizzy, and the dizziness was to the point she felt it wouldn't be safe to drive. She doesn't know if she should contribute that to the vaccine or not. On day 15, the patient clarified as last night at around 14:30 she started to get dizzy again and she was continuing to be extremely dizzy. Caller stated she will get in the bed and hope this dizziness will go away. The patient stated that she has only been dizzy on those 2 days- the 7th day from the shot and the 15th day. The outcome of event was not recovered.   No further details were provided or obtained.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.